FluLaval Quadrivalent (influenza vaccine) / GSK - LARVOL DELTA

RIVER: Randomized Influenza Vaccine Evaluation of Immune Response (clinicaltrials.gov) - P4 | N=366 | Completed | Sponsor: Marshfield Clinic Research Foundation | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Influenza • Respiratory Diseases

Absolute and Relative Effectiveness of Cell- and Egg-based Quadrivalent Inactivated Influenza Vaccine Products from 2014-2015 to 2018-2019 seasons, U.S. Flu VE Network. (PubMed, Clin Infect Dis) - "Comparisons of influenza vaccine products over multiple seasons showed benefit against symptomatic laboratory-confirmed outpatient influenza of both egg- and cell culture-based quadrivalent inactivated influenza vaccines, with similar absolute and relative levels of protection provided by each product."

Journal • Infectious Disease • Influenza • Respiratory Diseases

RIVER: Randomized Influenza Vaccine Evaluation of Immune Response (clinicaltrials.gov) - P4 | N=366 | Active, not recruiting | Sponsor: Marshfield Clinic Research Foundation | Trial completion date: Sep 2022 ➔ Dec 2023

Trial completion date • Infectious Disease • Influenza • Respiratory Diseases

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae (clinicaltrials.gov) - P2 | N=140 | Recruiting | Sponsor: University of North Carolina, Chapel Hill | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease